Sophia Genetics SA reports results for the quarter ended in September - Earnings Summary

Sophia Genetics SA

08/11/2022 14:32

* Sophia Genetics SA  SOPH.OQ  reported a quarterly adjusted
loss
of 30 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 38 cents per share.
    * Revenue rose 12.4% to $11.65 million from a year ago;
analysts
expected $11.45 million. 
    * Sophia Genetics SA's reported EPS for the quarter was a
loss
of 36 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sophia Genetics SA shares had fallen by 26.2% this
quarter and
lost 86.2% so far this year.
    * The company reported a quarterly loss of $23.31 million.
    * Wall Street's median 12-month price target for Sophia
Genetics
SA is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -0.30          Beat
 Jun. 30 2022      -0.39          -0.31          Beat
 Mar. 31 2022      -0.33          -0.34          Missed
 Dec. 31 2021      -0.36          -0.28          Beat